{
    "nctId": "NCT00340600",
    "briefTitle": "Continuation of Follow-up of DES-Exposed Cohorts",
    "officialTitle": "Continuation of Follow-up of DES-Exposed Cohorts",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Autoimmune Disease, Prostate Cancer, Ovarian Cancer, Endometrial Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 10805,
    "primaryOutcomeMeasure": "Cancer",
    "eligibilityCriteria": "* INCLUSION CRITERIA:\n\nExposed daughters and unexposed daughters originally identified at: Baylor College of Medicine, University of Southern California (USC), Gunderson Clinic, Mayo Clinic, and Massachusetts General Hospital (MGH).\n\nMale and female offspring of mothers who were enrolled in a clinical trial to assess the effectiveness of DES at the University of Chicago.\n\nOffspring of mothers who were treated with DES by an infertility specialist, Dr. Herbert Horne, in the Boston area.\n\nOffspring of DES-exposed mothers and unexposed mothers who were followed for breast cancer risk during the 1980s.\n\nExposed sons and unexposed sons who were originally identified and followed at the Mayo Clinic during the late1970's for the occurrence of cancer, genital abnormalities and infertility.\n\nSubjects from the Registry for Research on Hormonal Transplacental Carcinogenesis.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}